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EmperipolesisAbstract Rosai Dorfman disease (RDD) is a rare, benign disease of unknown aetiology. It typi-
cally presents with massive, painless cervical lymphadenopathy but may have a varied presentation.
We report a paediatric case of RDD with initial isolated involvement of nasal cavity and PNS with
subsequent involvement of cervical lymph nodes. Endoscopic biopsy confirmed the pathological
diagnosis and he was managed successfully with medical therapy. At 20 month follow up there
was no evidence of recurrence. The ideal protocol for the treatment is still debated. A long term
follow-up is warranted to detect relapses. This case report is illustrated aiming at developing
insights into management and diagnosis of such rare clinical entity in a paediatric patient.
 2015 Egyptian Society of Ear, Nose, Throat and Allied Sciences. Production and hosting by Elsevier B.V.
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Rosai Dorfman syndrome is an immune mediated histoprolif-
erative disease described by Rosai and Dorfman in 1969. Other
theories like infectious origin have also been suggested however
the immunological theory has been the most accepted one.1
It commonly affects children and young adults. It is marked
by massive cervical lymphadenopathy with a low grade fever.
Detailed investigative workup may show anaemia, leucocytosis
and polyclonal hypergammaglobulinemia. The enlarged nodes
show the proliferation of sinusoidal histiocytes. Approxi-
mately 43% of cases show extra nodal involvement whereinthe possible sites are skin, central nervous system, ear, and
orbit and rarely nose and paranasal sinuses.2
Usually the treatment of choice is medical therapy using a
cocktail of steroid and cytotoxic drugs as in our case steroid
and cyclophosphamide were administered. However in refrac-
tory cases or in cases where the adenopathy is causing pressure
effects, treatment options like radiation and surgery can also
be considered. This entity has an indolent course with a possi-
bility of spontaneous remission even after long periods. Hence
these patients require a long term follow up.3
2. Case report
An eight year old child presented to the outpatient department
with a history of progressive left sided nasal block for the last
4 months with associated intermittent epistaxis for the last.
Figure 2 MRI T2 image in coronal view.
Figure 3 MRI T1 sagittal view.
44 G. Ashish et al.1 month. He also gave a history of bilateral rapidly progressive
neck swelling for the last 1 month. He has no other known
comorbidities.
Neck examination revealed multiple bilateral cervical lym-
phadenopathies. Level 2 lymph node on the left side and level
1b on right side were significantly enlarged measuring
5 cm  5 cm and 1.5 cm  1.5 cm, respectively. He had no
other palpable lymph nodes or organomegaly. Haematological
and immunological workups were irrelevant. A diagnostic
nasal endoscopy revealed a friable mass involving the left lat-
eral wall and inferior turbinate going up to the choana.
MRCT scan T2 images revealed a 3.4  2.7  2.4 cm sized
T2 isointense lesion in the left nasal cavity (Fig. 1) The mass
was involving the left inferior turbinate, lateral nasal wall with
bowing of the medial wall of the maxillary sinus (Fig. 2) with
posterior extension up to the nasopharynx (Fig. 3).
Histopathological examination was consistent with extra nodal
sinus Histiocytosis (Figs. 4 and 5) with massive lym-
phadenopathy (Rosai–Dorfman disease). He was treated suc-
cessfully with oral steroid and low dose cyclophosphamide
and at 20 month follow up no evidence of recurrence or resid-
ual disease was noted. Repeat nasal endoscopy showed no
lesion in the nasal cavity and there were no palpable cervical
lymph nodes.
3. Discussion
Rosai Dorfman syndrome, well known as Sinus Histiocytosis
with Massive Lymphadenopathy (SHML), is a rare benign sys-
temic histio-proliferative disease commonly involving cervical
group lymph nodes.1 It was first illustrated by Azoury and
Reed and later by Rosai and Dorfman in 1969.4
Presently SHML is classified as one of the non-Juvenile
Xanthogranulomas (non-JXG) under the sub-group of the
non-Langerhans Cell Histiocytosis (non-LCH).5
It commonly affects a younger age group, usually in the
first and second decades with a male-to-female preponderance
of 1.4:1.6
Aetiology is still debated, however immune mediated the-
ory or infections caused by Epstein Barr Virus, brucella or
klebsiella have been the two most proposed theories.2Figure 1 CT scan coronal view.
Figure 4 H&E stain – showing cells arranged in solid sheets,
with round to oval, irregular, vesicular nuclei, prominent nucleoli
and moderate amounts of eosinophilic to vacuolated cytoplasm.
The background contains many plasma cells and lymphocytes.Lymph nodes are usually involved but in about 43% of
cases, however extra nodal involvement is also well known.
Frequently involved extra nodal sites are skin, mucosa, spinal
cord, pancreas, nasal cavity and major salivary glands.7
Those affected with this disease present with massive, pain-
less, bilateral or unilateral cervical lymphadenopathy with
other nodal sites such as axillary, inguinal, para aortic and
mediastinal lymph nodes.8
Figure 5 H&E stain – showing evidence of Emperipolesis.
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extensively distended sinuses, with abundant histiocytes with
vesicular nuclei, distinct nucleoli and abundant pale cytoplasm
demonstrating Emperipolesis. Emperipolesis was proposed by
Humble et al., in 1956 as, ‘‘the active penetration of one cell by
another which remains intact”. It differs from phagocytosis
because the engulfed cell exists within another cell, remains
viable, and can exit without disturbing the physiological and
morphological aspects.9 Emperipolesis till date is considered
as an important pathognomonic feature of Rosai Hoffman’s
disease. This may be less evident in extranodal involvement.10
Histological differential diagnosis includes lymphomas,
Hodgkin’s disease, Langerhans Cell Histiocytosis X (LCH)
monocytic leukaemia and metastatic carcinoma.11 Characteris-
tic Immunohistochemical features including CD 68 and CD 1a
positivity, positive staining for S-100 and anti-chymotrypsin
help us to accurately diagnose SHML.12
The haematological picture usually demonstrates anaemia,
leukocytosis, neutrophilia and increased ESR.10
CT and magnetic resonance imaging should be used to
assess the territory of the lesion, more frequently if it involves
head and neck.13
Clinical scenario has generally insidious onset, protracted
duration of active disease state and eventual spontaneous
remission, but recurrences have also been reported
occasionally.14
The treatment options include surgery, chemotherapy, and
radiotherapy. However surgical option has been proposed to
give most promising results by far. RDD in nose and paranasal
sinuses can be treated by endoscopic approach or by external
approach such as craniofacial resection or midfacial degloving,
depending on the extent of the disease.15
Medical therapy for RDD includes corticosteroids, cyto-
toxic agents or both. Promising results have been obtained
by a combination of corticosteroid (prednisolone) along with
agents like vinca alkaloid (vincristine and vinblastine),
6-mercaptopurine, methotrexate, or alkylating agent
(cyclophosphamide).16
This clinical entity has an indolent course with approxi-
mately 50% of them resolving without any residual disease.
However in 1/3rd of patients residual adenopathy is noted
and remaining approximately 17% have unresolved symptoms
even after 5–10 years.3 In our case the child showed no residual
or recurrence at 20 month follow up.This disease frequently demonstrates spontaneous remission.
Pulsoni et al. demonstrated in his series of 80 patients that 80%
of patients had full remission.17 Surgical treatment becomes
important in cases of enlarged tissue with significant symptoms
such as compression on vital organs or airway obstruction.184. Conclusion
Our case demonstrates a rare clinical scenario of isolated
involvement of nose and paranasal sinuses with subsequent
involvement of bilateral cervical lymph nodes manages suc-
cessfully via medical therapy. The treating doctor needs to
be aware of the pathognomonic clinical features and hallmark
diagnostic features of this condition to be able to diagnose it
accurately. The disease process undergoes a frequent sponta-
neous remission indicating that conservative, expectant man-
agement is sufficient in most patients, but more aggressive
surgical treatment may be necessary in selected cases if war-
ranted, however consensus for treatment is controversial.
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